Key Highlights

● Palantir Technologies shares fell 7.22% to close at $186.03 on October 16.

● The consensus 12-month price target is $206.43, implying about 11.0% upside.

● Analysts are split 21 Buy, 8 Hold, and 3 Sell on the stock.

● Targets range from $80 to $265 across 32 analysts.

Palantir Technologies (NASDAQ:PLTR) closed at $186.03 on Friday October 16, 2026, with the shares listed on Nasdaq and a member of the Nasdaq-100. According to market data, the consensus mean 12-month price target is $206.43, which is 11.0% above the latest close (+11.0%). The shares fell 7.22% on the day, and the company is due to report third-quarter results on November 2, 2026.

Price targets are analyst forecasts rather than guarantees.

What Is the Latest Analyst Price Target?

The data shows a consensus mean target of $206.43 and a median of $217.50, with the highest target at $265.00 and the lowest at $80.00. The figures are drawn from 32 analysts, with the data dated October 16, 2026. Measured against the latest close, the mean target implies +11.0% and the median implies +16.9%.

If the consensus proves accurate, the shares would trade near the mean target over the next twelve months. However, the spread between the high and low targets shows that analysts hold differing views, and targets are routinely revised as new information emerges.

What Are Analysts Saying?

The consensus rating is Buy, with a split of 21 Buy, 8 Hold, 3 Sell. Mizuho Securities raised its target from $215 to $245 with a Buy rating on 15 October, Baird lifted its target from $200 to $250 on 12 October, Phillip Securities downgraded to Hold with a $215 target on 12 October, Barclays initiated at Buy with a $265 target on 8 October and Goldman Sachs upgraded to Buy with a $230 target on 8 October.

Analysts' views can change quickly, and individual broker actions should be read in the context of the wider consensus rather than in isolation.

What Could Help the Stock Reach the Price Target?

Recent target increases from Mizuho and Baird, the Goldman Sachs upgrade and the Barclays initiation suggest analyst sentiment has been constructive. Palantir also announced a collaboration with Customers Bank on AI-native banking. If commercial and government adoption of its software platforms continues, the consensus target suggests room for gains from the latest close.

None of this guarantees that the stock will reach the target, and outcomes will depend on company performance and market conditions.

What Could Prevent the Stock Reaching the Target?

The range of targets is exceptionally wide, from $80 to $265, and the lowest target is 57% below the latest close, signalling sharp disagreement about valuation. Three analysts rate the stock Sell. Reports that its patient data technology has been rejected by many NHS trusts in England highlight reputational and political risks, and the sharp one-day fall shows the shares can be volatile.

What Should Investors Watch Next?

Third-quarter results on 2 November will be the main event, including revenue growth, commercial customer additions and guidance. Investors may also follow further target revisions, contract announcements and any news affecting public-sector relationships. Next earnings date: November 2, 2026.

Still Building the Case

The consensus target suggests +11.0% from the latest close of $186.03, but the figure is a forecast and not a certainty.